NCT05108350: A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects |
|
|
| Not yet recruiting | 1 | 80 | NA | T1: FDC 5/500 mg; R1+R: SHR3824 5 mg + Metformin 500 mg XR, T2: FDC 5/1000 mg; R2+R: SHR3824 5 mg + two Metformin 500 mg XR | Shandong Suncadia Medicine Co., Ltd. | Type II Diabetes | 12/21 | 12/21 | | |